MAP2K4 and cancer: Although increased proliferation and resistance to apoptosis are characteristics of cancer, in mice with stable intrahepatic MKK4-knockdown, no tumors could be observed, indicating that the absence of MKK4 is not a strong tumor-initiating factor and making MKK4 a promising target for transient pharmacological inhibition and a liver regeneration therapeutic [119].